A detailed history of Prestige Wealth Management Group LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 19 shares of CRL stock, worth $3,793. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 19 -0.0%
Holding current value
$3,793
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 01, 2022

SELL
$182.44 - $250.54 $729 - $1,002
-4 Reduced 17.39%
19 $4,000
Q2 2022

Aug 10, 2022

BUY
$204.13 - $302.4 $816 - $1,209
4 Added 21.05%
23 $5,000
Q1 2020

May 15, 2020

BUY
$98.9 - $178.34 $1,879 - $3,388
19 New
19 $2,000
Q1 2019

Aug 16, 2019

SELL
$104.82 - $146.73 $3,773 - $5,282
-36 Closed
0 $0
Q4 2018

Apr 16, 2019

BUY
$105.09 - $137.23 $3,783 - $4,940
36 New
36 $4,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.2B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.